210
Views
8
CrossRef citations to date
0
Altmetric
Perspectives

The SPUR Model: A Framework for Considering Patient Behavior

Pages 97-105 | Published online: 16 Jan 2020

References

  • Sabaté E, World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
  • Aitken M, Gorokhovich L. Advancing the responsible use of medicines: applying levers for change. SSRN J. 2012. doi:10.2139/ssrn.2222541
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011. doi:10.1002/14651858.CD000011.pub3.
  • Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83(7):858–873. doi:10.1097/01.tp.0000258599.65257.a6
  • Atkinson T, Rodríguez V, Gordon M, et al. The association between patient-reported and objective oral anticancer medication adherence measures: a systematic review. ONF. 2016;43(5):576–582. doi:10.1188/16.ONF.576-582
  • Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887.e1. doi:10.1016/j.amjmed.2011.12.013
  • Roth HP, Caron HS. Accuracy of doctors’ estimates and patients’ statements on adherence to a drug regimen. Clin Pharmacol Ther. 1978;23(3):361–370. doi:10.1002/cpt1978233361
  • Copher R, Buzinec P, Zarotsky V, Kazis L, Iqbal SU, Macarios D. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims. Curr Med Res Opin. 2010;26(4):777–785. doi:10.1185/03007990903579171
  • Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis. 2011;17(2):599–604. doi:10.1002/ibd.21310
  • Clyne W, McLachlan S, Mshelia C, et al. “My patients are better than yours”: optimistic bias about patients’ medication adherence by European health care professionals. Patient Prefer Adherence. 2016;10:1937–1944. doi:10.2147/PPA.S108827
  • Schulz PJ, Nakamoto K “Bad” literacy, the Internet, and the limits of patient empowerment. In: 2011 AAAI Spring Symposium Series; Palo Alto, CA, 2011. http://www.aaai.org/ocs/index.php/SSS/SSS11/paper/view/2430. .
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Canonica GW, Baena-Cagnani CE, Blaiss MS, et al. Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) survey: global adult findings. Allergy. 2007;62(6):668–674. doi:10.1111/j.1398-9995.2007.01352.x
  • Greene J, Hibbard JH, Alvarez C, Overton V. Supporting patient behavior change: approaches used by primary care clinicians whose patients have an increase in activation levels. Ann Fam Med. 2016;14(2):148–154. doi:10.1370/afm.1904
  • Regina Corso Consulting. 2017 Patient Survey Report for the Physicians Foundation. Presented at the:
  • Tan X, Patel I, Chang J. Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8). Inov Pharm. 2014;5:3. doi:10.24926/iip.v5i3.347
  • Dolgin K. The Impact of text messaging in adherence programs. Eur J Person Centered Healthcare. 2015;3:1. doi:10.5750/ejpch.v3i1
  • Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth Chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015;17(2):e52. doi:10.2196/jmir.3951
  • Wu Y, Yao X, Vespasiani G, et al. Mobile App-based interventions to support diabetes self-management: a systematic review of randomized controlled trials to identify functions associated with glycemic efficacy. JMIR Mhealth Uhealth. 2017;5:3. doi:10.2196/mhealth.6522
  • Subbaraman R, de Mondesert L, Musiimenta A, et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health. 2018;3(5):e001018. doi:10.1136/bmjgh-2018-001018
  • Kassavou A, Houghton V, Edwards S, Brimicombe J, Sutton S. Development and piloting of a highly tailored digital intervention to support adherence to antihypertensive medications as an adjunct to primary care consultations. BMJ Open. 2019;9(1):e024121. doi:10.1136/bmjopen-2018-024121
  • Smallwood RD (54) BAYESIAN PRODUCT RECOMMENDATION ENGINE.:12.
  • Prochaska JO, Redding C, Evers K. The transtheoretical model and stage of change. In: Health Behavior and Health Education. Karen Glanz, Barbara K. Rimer, Frances Marcus Lewis, (Eds). San Francisco, CA: Jossey-Bass Inc; 2002:60-84
  • Green EC, Murphy E. Health belief model. In: Cockerham WC, Dingwall R, Quah S, editors. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. Chichester, UK:John Wiley & Sons, Ltd; 2014:766–769. doi:10.1002/9781118410868.wbehibs410.
  • Carpenter CJ. A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Commun. 2010;25(8):661–669. doi:10.1080/10410236.2010.521906
  • Ajzen I. From intentions to actions: a theory of planned behavior. In: Action Control. SSSP Springer Series in Social Psychology. Julius Kuhl, Jürgen Beckmann (Eds). Berlin, Germany: Springer Berlin Heidelberg; 1985:11–39.
  • Montano D, Kazprzyk D. Theory of reasoned action, theory of planned behavior, and the integrated behavioral model. In: Health Behavior: Theory, Research and Practice. Karen Glanz, Barbara K. Rimer, K. Viswanath (Eds), 5th ed. San Francisco, CA: Jossey-Bass Inc; 2015:95-124
  • Riekert KA, Ockene JK, Pbert L, eds. Handbook of health behavior change. 4th ed. New York, NY: Springer Publishing Company, LLC; 2014.
  • Glanz K, Rimer BK, Viswanath K, eds. Health behavior: theory, research, and practice. Fifth ed. San Francisco, CA: Jossey-Bass & Pfeiffer Imprints, Wiley; 2015.
  • Reach G. A novel conceptual framework for understanding the mechanism of adherence to long term therapies. Patient Prefer Adherence. 2008;2:7.
  • Belk W. Possessions and the extended self. J Consum Res. 1988;15:139–168. doi:10.1086/jcr.1988.15.issue-2
  • Graffigna G, Barello S. Spotlight on the Patient Health Engagement model (PHE model): a psychosocial theory to understand people’s meaningful engagement in their own health care. Patient Prefer Adherence. 2018;12:1261–1271. doi:10.2147/PPA.S145646
  • Shillington A, Ganjuli A, Clewell J. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. PPA. 2016;711. doi:10.2147/PPA.S101175
  • Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4p1):1005–1026. doi:10.1111/j.1475-6773.2004.00269.x
  • Greene J, Hibbard JH, Sacks R, Overton V, Parrotta CD. When patient activation levels change, health outcomes and costs change, too. Health Aff. 2015;34(3):431–437. doi:10.1377/hlthaff.2014.0452
  • Kinney RL, Lemon SC, Person SD, Pagoto SL, Saczynski JS. The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: a systematic review. Patient Educ Couns. 2015;98(5):545–552. doi:10.1016/j.pec.2015.02.005
  • Conner M, Sparks P. Theory of planned behaviour and health behaviour. In: Predicting Health Behaviour: Research and Practice with Social Cognition Models. 2nd ed. Maidenhead: Open Univ. Press; 2007: 121-162.
  • Bane C, Hughe CM, McElnay JC. Determinants of medication adherence in hypertensive patients: an application of self-efficacy and the Theory of Planned Behaviour. Int J Pharm Pract. 2006;14(3):197–204. doi:10.1211/ijpp.14.3.0006
  • Saal W, Kagee A. The applicability of the theory of planned behaviour in predicting adherence to ART among a South African sample. J Health Psychol. 2012;17(3):362–370. doi:10.1177/1359105311416875
  • Sniehotta FF, Presseau J, Araújo-Soares V. Time to retire the theory of planned behaviour. Health Psychol Rev. 2014;8(1):1–7. doi:10.1080/17437199.2013.869710
  • McEachan RRC, Conner M, Taylor NJ, Lawton RJ. Prospective prediction of health-related behaviours with the theory of planned behaviour: a meta-analysis.:49. Health Psychol Rev. 2011;5(2):97–144. doi:10.1080/17437199.2010.521684
  • Rothman AJ, Salovey P. Shaping perceptions to motivate healthy behavior: the role of message framing.:17. Psychol Bull. 1997;121(1):3. doi:10.1037/0033-2909.121.1.3
  • McEachan R. Meta-analysis of the Reasoned Action Approach (RAA) to understanding health behaviors. Ann Behav Med. 2016;50:21.
  • Amico KR, Mugavero M, Krousel-Wood MA, Bosworth HB, Merlin JS. Advantages to using social-behavioral models of medication adherence in research and practice. J Gen Intern Med. 2018;33(2):207–215. doi:10.1007/s11606-017-4197-5
  • Gu L, Wu S, Zhao S, et al. Association of social support and medication adherence in chinese patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2017;14(12):1522. doi:10.3390/ijerph14121522
  • Shallcross AJ, Becker DA, Singh A, et al. Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy. Epilepsy Behav. 2015;46:242–245. doi:10.1016/j.yebeh.2015.01.034
  • Kim S-H, McDonald S, Kim S, Foster C, Fidler S. Importance of self-motivation and social support in medication adherence in HIV-infected adolescents in the United Kingdom and Ireland: a multicentre HYPNet study. AIDS Patient Care STDS. 2015;29(6):354–364. doi:10.1089/apc.2014.0335
  • Baer JS, Stacy A, Larimer M. Biases in the perception of drinking norms among college students. J Stud Alcohol. 1991;52(6):580–586. doi:10.15288/jsa.1991.52.580
  • De Las Cuevas C, Peñate W, Sanz EJ. The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression. BMC Psychiatry. 2014;14(1). doi:10.1186/s12888-014-0324-6
  • Goldstein CM, Gathright EC, Garcia S. Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team. PPA. 2017;11:547–559. doi:10.2147/PPA.S127277
  • Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Dia Care. 2008;31(12):2398–2403. doi:10.2337/dc08-1341
  • Yun LWH, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. JAIDS. 2005;38(4):432–438. doi:10.1097/01.qai.0000147524.19122.fd
  • Kortte KB, Wegener ST. Denial of illness in medical rehabilitation populations: theory, research, and definition. Rehabil Psychol. 2004;49(3):187–199. doi:10.1037/0090-5550.49.3.187
  • Prince R, Frasure-Smith N, Rolicz-Woloszyk E. Life stress, denial and outcome in ischemic heart disease patients. J Psychosom Res. 1982;26(1):23–31. doi:10.1016/0022-3999(82)90059-9
  • Levine J, Warrenburg S, Kerns R, et al. The role of denial in recovery from coronary heart disease. J Biobehav Med. Published 1987. http://journals.lww.com/psychosomaticmedicine/Fulltext/1987/03000/The_role_of_denial_in_recovery_from_coronary_heart.1.aspx. Accessed, 2015.
  • Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J Affect Disord. 2000;59(3):237–241. doi:10.1016/S0165-0327(99)00152-4
  • Aldebot S, Weisman de Mamani AG. Denial and acceptance coping styles and medication adherence in schizophrenia. J Nerv Ment Dis. 2009;197(8):580–584. doi:10.1097/NMD.0b013e3181b05fbe
  • Ganasegeran K, Rashid A. The prevalence of medication nonadherence in post-myocardial infarction survivors and its perceived barriers and psychological correlates: a cross-sectional study in a cardiac health facility in Malaysia. PPA. 2017;11:1975–1985. doi:10.2147/PPA.S151053
  • Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 2008;67(2):301–310. doi:10.1016/j.socscimed.2008.03.042
  • Belk RW. Extended self and extending paradigmatic perspective. J Consum Res. 1989;16(1):129–132. doi:10.1086/jcr.1989.16.issue-1
  • Ahuvia AC. Beyond the extended self: loved objects and consumers’ identity narratives. J Consum Res. 2005;32(1):171–184. doi:10.1086/429607
  • Kashima Y, Yamaguchi S, Kim U, Choi SC, Gelfand MJ, Yuki M. Culture, gender, and self: a perspective from individualism-collectivism research. J Pers Soc Psychol. 1995;69(5):925–937. doi:10.1037/0022-3514.69.5.925
  • Fogarty JS, Youngs GA. Psychological reactance as a factor in patient noncompliance with medication taking: a field experiment1. J Appl Soc Psychol. 2000;30(11):2365–2391. doi:10.1111/j.1559-1816.2000.tb02441.x
  • Tversky A, Kahneman D. Loss aversion in riskless choice: a reference-dependent model. Q J Econ. 1991;106(4):1039–1061. doi:10.2307/2937956
  • Zhao X, Villagran MM, Kreps GL, McHorney C. Gain versus loss framing in adherence-promoting communication targeting patients with chronic diseases: the moderating effect of individual time perspective. Health Commun. 2012;27(1):75–85. doi:10.1080/10410236.2011.569002
  • Lebeau G, Consoli SM, Le Bouc R, et al. Delay discounting of gains and losses, glycemic control and therapeutic adherence in type 2 diabetes. Behav Processes. 2016;132:42–48. doi:10.1016/j.beproc.2016.09.006
  • Zullig LL, Peppercorn JM, Schrag D, et al. Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract. 2013;9(6S):60s–63s. doi:10.1200/JOP.2013.000971
  • Turner AP, Williams RM, Sloan AP, Haselkorn JK. Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis. Rehabil Psychol. 2009;54(1):116–121. doi:10.1037/a0014460